BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canadian Securities Exchange (CSE) Level 1 and 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $738.72 only $295.49

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.99
0.42%
US Tech 100
20,389.60
0.88%
S&P 500
6,032.38
0.56%
US Dollar vs CAD
1.40155
0.00%
Bitcoin
96,454.15
0.02%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Pulmonx Corporation (LUNG) Share Price

Pulmonx Corporation

Pulmonx Corporation (LUNG)

NASDAQ
6.45
0.15
(2.38%)
Closed November 30 3:00PM
Delayed by 15 minutes
6.45
0.00
(0.00%)
After Hours: 2:59PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
6.45
Bid
5.72
Ask
8.19
Volume
48,105
6.29 Day's Range 6.54
5.46 52 Week Range 14.92
Market Cap
254.697M
Previous Close
6.30
Open
6.29
Last Trade
136
@
6.54
(formt)
Last Trade Time
Financial Volume
US$ 307,550
VWAP
6.3933
Average Volume (3m)
227,774
Shares Outstanding
39,487,879
Dividend Yield
-
PE Ratio
-4.19
Earnings Per Share (EPS)
-1.54
Revenue
68.68M
Net Profit
-60.84M

About Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment ... Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.pulmonx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Pulmonx Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LUNG. The last closing price for Pulmonx was US$6.30. Over the last year, Pulmonx shares have traded in a share price range of US$ 5.46 to US$ 14.92.

Pulmonx currently has 39,487,879 shares outstanding. The market capitalization of Pulmonx is US$248.77 million. Pulmonx has a price to earnings ratio (PE ratio) of -4.19.

Ask ADVFN Intelligence (AI)

LUNG Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

November 26 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

November 22 2024
Edgar (US Regulatory)

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...

November 20 2024
GlobeNewswire Inc.

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for...

November 19 2024
Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 14 2024
Edgar (US Regulatory)

Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

REDWOOD CITY, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...

November 07 2024
GlobeNewswire Inc.

Pulmonx to Present at the Stifel 2024 Healthcare Conference

REDWOOD CITY, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced...

November 05 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 01 2024
Edgar (US Regulatory)

Form 8-K - Current report

October 30 2024
Edgar (US Regulatory)

Pulmonx Reports Third Quarter 2024 Financial Results

REDWOOD CITY, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...

October 30 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.010.1552795031066.447.096.252164266.64431073CS
40.132.056962025326.327.825.842213196.8086384CS
12-0.29-4.302670623156.748.795.842277747.17726264CS
26-1.38-17.62452107287.838.795.463011736.91610995CS
52-4.66-41.944194419411.1114.925.463755228.89029465CS
156-28.14-81.352992194334.5936.374.0739904013.28135169CS
260-31.55-83.02631578953869.47794.0737948720.7984338CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BSLKBolt Projects Holdings Inc
US$ 0.71
(139.86%)
80.81M
PRZOParaZero Technologies Ltd
US$ 1.24
(94.14%)
205.02M
AIEVThunder Power Holdings Inc
US$ 0.47
(87.25%)
122.71M
PASGPassage Bio Inc
US$ 1.13
(69.52%)
15.44M
EPOWSunrise New Energy Company Ltd
US$ 1.06
(45.21%)
314.9k
APLTApplied Therapeutics Inc
US$ 2.03
(-76.31%)
43.9M
TGLTreasure Global Inc
US$ 0.2944
(-29.08%)
1.85M
PROCProcaps Group SA
US$ 1.51
(-27.75%)
106.08k
SHOTWSafety Shot Inc
US$ 0.104
(-20.00%)
1.43k
MONDMondee Holdings Inc
US$ 0.7102
(-19.59%)
297.63k
PRZOParaZero Technologies Ltd
US$ 1.24
(94.14%)
205.02M
NVDANVIDIA Corporation
US$ 138.25
(2.15%)
141.86M
AIEVThunder Power Holdings Inc
US$ 0.47
(87.25%)
122.71M
RGTIRigetti Computing Inc
US$ 3.05
(27.08%)
116.98M
MARAMARA Holdings Inc
US$ 27.42
(1.86%)
89.54M

Discussion

View Full Feed
green maschine green maschine 2 minutes ago
Disregard the part about Gaza. That damn Netanyahu doesn't want to stop the bombing.
$$SVRE$$
SVRE
FrostyStar1 FrostyStar1 2 minutes ago
Thats not wealth thats income. You said Trump gave tax cuts to the rich.

You cant tax wealth you can only tax income. You have no clue what you are talking about.
STHC
Controlledoilandgas Controlledoilandgas 3 minutes ago
Can you post what you're seeing?
AZRH
nowwhat2 nowwhat2 3 minutes ago
"Ya' pays yer money, ya' takes yer chances".......
I never much liked this sleazeball from Day 1
Why, I've even suspected that Mackie shorted IBAT


https://www.youtube.com/watch?v=iNGH9C5ntCU
IBATF
TradingCharts TradingCharts 4 minutes ago
SiCore: Amprius Launches New Silicon Anode Battery Platform
SiCore batteries are based on an innovative silicon anode material system delivering high-energy-density silicon anode batteries that reportedly surpasses current graphite cell performance
By Abi Wylie / 25 Jan 2024
AMPX
FrostyStar1 FrostyStar1 4 minutes ago
Dictatorship? You mean like when democrats threw 14 million votes for Joe Biden in the trash. Ran a coup on Joe Biden and installed Kamela without even a vote? Kamela got 1% of the primary vote in 2020 and installed in 2024 with zero qualifications.

Democrats are in no position to
STHC
catdaddy catdaddy 4 minutes ago
Answer the question, Mr. Fraud.

Regarding risk, Investor, don't forget your infatuation with the class action lawsuit you warned us about for months. It was going to be our death. Would you tell us the current status?
AVXL
catdaddy catdaddy 4 minutes ago
Answer the question, Mr. Fraud.

Regarding risk, Investor, don't forget your infatuation with the class action lawsuit you warned us about for months. It was going to be our death. Would you tell us the current status?
AVXL
sage4 sage4 5 minutes ago
Thank you for all your D.D. and sahring it here.
AVXL
Papa Grizz Papa Grizz 8 minutes ago
31 now- sttn at 135 thou profit -hmmmm, patience is da key now. I'd feel really miffed if it went ballistic and I was out. Lookn for .001 which is where my Exit Ramp is firmly placed. Looks to be movn on up. "ALL ABOARD" SHIBA ARMY-STRONG AND HODL LONG
SHIBUSD
Investor2014 Investor2014 9 minutes ago
Any thoughts on those types of reasons for EMA not approving despite an 83% chance of approval based the agency’s ‘recommendation’ to file an MAA and how that might potentially apply to Anavex?
AVXL
Zorax Zorax 11 minutes ago
Thanks. That was much better. I was just going to write 'his own'.
nowwhat2 nowwhat2 12 minutes ago
Yup....Still in glitch-mode ;


Navigating to this url
https://ih.advfn.com/crypto/Bitcoin-BTC/chart/real-time

SHOULD take one to a page which looks much like this ;

https://investorshub.advfn.com/uimage/uploads/2024/11/30/ofpepihub_glitch_
BTCUSD
gp22 gp22 15 minutes ago
$VVOS @ $3.30s: Microfloat. Cash rich. Recent FDA Approval of only device for Sleep Apnea. Upgraded two weeks ago to $6.00+ Valuation....New Sleep Apnea patent granted last week.
Coming off lows on elevated volume last week. ..Super tight Float. Moving up...$VVOS ripe. Should moving nicely hi
VVOS
gp22 gp22 16 minutes ago
$VVOS @ $3.30s: Microfloat. Cash rich. Recent FDA Approval of only device for Sleep Apnea. Upgraded last week to $6.00+ Valuation....New Sleep Apnea patent granted this week.
Coming off lows on elevated volume last week. ..Super tight Float. Moving up...$VVOS ripe. Should moving nicely higher
VVOS
gitreal gitreal 16 minutes ago
A bit of an uphill climb for this diluted garbage:

Authorized Shares
20,000,000,000
11/27/2024

Jared better come up with some particularly juicy lies to make this move.

https://investorshub.advfn.com/uimage/uploads/2023/11/27/ymhgxgizmo.
NBRI
mailman69 mailman69 19 minutes ago
Everything works great in a dictatorship because one man decides what it will be and you have to follow it and that's it. Democracy may Maybe not perfect but it's better than having someone else decide for us like Trump will do
STHC
Jetmek_03052 Jetmek_03052 19 minutes ago
Sylvia, learn to spell.
DBMM
mailman69 mailman69 20 minutes ago
Also, reversing Roe versus Wade did nothing but send it to the states and create 50 to 1000 different regulations instead of having a standard that the federal government has set
STHC
mailman69 mailman69 22 minutes ago
No, you're wrong. A person who makes 100 to 200,000 saved if they're lucky $1000 the person that makes $500,000-$1 million saves 50 or $60,000 in taxes. It's a fact the deficit for the last tax cut the Trump dead is trillions of dollars that's a fact.
STHC
Investor2014 Investor2014 23 minutes ago
Have them play chess and drink beer?
AVXL

Your Recent History

NASDAQ
LUNG
Pulmonx
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canada: TSX and TSXV Level 1

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1305.00 only $522.00